Literature DB >> 10382083

Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.

M Macaluso1, L Lawson, R Akers, T Valappil, K Hammond, R Blackwell, G Hortin.   

Abstract

Forty women participated in three clinic visits during which they were exposed to their partner's semen (10 microL, 100 microL, and 1 mL). At each visit they took vaginal fluid samples before exposure to their partner's semen, immediately after, and at 1, 24, and 48 h after exposure. PSA was measured with an enzyme-linked immunoassay. The mean PSA level for preexposure swabs ranged between 0.43 and 0.88 ng/mL. The mean PSA levels were 193 immediately after exposure to 10 microL, 472 after 100 microL, and 19,098 after 1 mL. The PSA levels declined within 1 h, and returned to background at 48 h. The findings confirm that our procedure is a sensitive and specific method for detecting recent semen exposure, and indicate that PSA levels depend on exposure intensity and time since exposure. Application of this method in condom efficacy studies provides objective evidence of condom failure that enhances the interpretation of self-report.

Entities:  

Keywords:  Antigens; Barrier Methods; Biology; Condom; Condom Failure; Contraception; Contraceptive Methods; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Genitalia, Male; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Physiology; Prostate; Research Report; Urogenital System; Vagina

Mesh:

Substances:

Year:  1999        PMID: 10382083     DOI: 10.1016/s0010-7824(99)00013-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  55 in total

1.  Objective non-intrusive markers of sperm production and sexual activity.

Authors:  Thilee Sivananthan; Franz Bathur; Mark Jimenez; Ann Conway; Amanda Idan; David Handelsman
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

2.  Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA.

Authors:  Roxanne Jamshidi; Ana Penman-Aguilar; Jeffrey Wiener; Maria F Gallo; Jonathan M Zenilman; J H Melendez; Margaret Snead; Carolyn M Black; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2013-08-14       Impact factor: 3.375

3.  A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.

Authors:  Anna Månberg; Frideborg Bradley; Ulrika Qundos; Brandon L Guthrie; Kenzie Birse; Laura Noël-Romas; Cecilia Lindskog; Rose Bosire; James Kiarie; Carey Farquhar; Adam D Burgener; Peter Nilsson; Kristina Broliden
Journal:  Mol Cell Proteomics       Date:  2018-11-30       Impact factor: 5.911

4.  Differences in misreporting of sexual behavior over time: implications for HIV trials.

Authors:  Maria F Gallo; Lee Warner; Marcia M Hobbs; Denise J Jamieson; Tina Hylton-Kong; Markus J Steiner
Journal:  Sex Transm Dis       Date:  2015-03       Impact factor: 2.830

5.  Prostate-specific antigen concentration in vaginal fluid after exposure to semen.

Authors:  Andrzej Kulczycki; Ilene Brill; Margaret Christine Snead; Maurizio Macaluso
Journal:  Contraception       Date:  2017-07-12       Impact factor: 3.375

6.  Alcohol Use and Associations With Biological Markers and Self-Reported Indicators of Unprotected Sex in Human Immunodeficiency Virus-Positive Female Sex Workers in Mombasa, Kenya.

Authors:  Darcy White; Kate S Wilson; Linnet N Masese; George Wanje; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; John Kinuthia; Jane M Simoni; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

7.  The use of biomarkers of semen exposure in sexual and reproductive health studies.

Authors:  Margaret Christine Snead; Carolyn M Black; Athena P Kourtis
Journal:  J Womens Health (Larchmt)       Date:  2014-09-30       Impact factor: 2.681

8.  Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during sexually transmitted infection and reproductive tract infection treatment among female sexually transmitted infection clinic patients.

Authors:  Clive Anderson; Maria F Gallo; Tina Hylton-Kong; Markus J Steiner; Marcia M Hobbs; Maurizio Macaluso; J Peter Figueroa; Denise J Jamieson; Jennifer Legardy-Williams; Jeffrey Wiener; Lee Warner
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

9.  Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.

Authors:  Renee Heffron; Urvi M Parikh; Kerri J Penrose; Nelly Mugo; Deborah Donnell; Connie Celum; John W Mellors; Jared M Baeten
Journal:  AIDS Behav       Date:  2017-07

Review 10.  The validity of self-reported behaviors: methods for estimating underreporting of risk behaviors.

Authors:  Marlena S Norwood; James P Hughes; K Rivet Amico
Journal:  Ann Epidemiol       Date:  2016-08-08       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.